Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension
NCT02242383 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13248
Last updated 2014-09-17
Summary
To evaluate efficacy and tolerability of Micardis® / MicardisPlus® under usual daily-practice prescribing conditions with a special emphasis on controlling morning blood pressure
Conditions
Interventions
- DRUG
-
Telmisartan
- DRUG
-
Telmisartan in combination with hydrochlorothiazide
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-31
- Primary Completion
- 2005-10-31
More Related Trials
-
Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension
NCT02177422 ·Status: COMPLETED ·Phase: PHASE3
-
Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension
NCT02242838 ·Status: COMPLETED
-
Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure
NCT02242864 ·Status: COMPLETED
-
Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension
NCT02242370 ·Status: COMPLETED ·Phase: PHASE4
-
Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension
NCT02238275 ·Status: COMPLETED
-
A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)
NCT02242396 ·Status: COMPLETED
-
Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus
NCT02242825 ·Status: COMPLETED
-
Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients
NCT00904371 ·Status: COMPLETED
-
A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension
NCT00133185 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)
NCT02243566 ·Status: COMPLETED
-
An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension
NCT00904215 ·Status: COMPLETED
-
Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension
NCT02183701 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice
NCT00982735 ·Status: COMPLETED
-
Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters
NCT00615108 ·Status: COMPLETED
-
Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)
NCT02262637 ·Status: COMPLETED
-
Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension
NCT02245464 ·Status: COMPLETED
-
Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients
NCT01108809 ·Status: COMPLETED
-
Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension
NCT02177409 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects
NCT02218684 ·Status: COMPLETED ·Phase: PHASE1
-
Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension
NCT00659607 ·Status: COMPLETED
-
Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension
NCT02242344 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives
NCT00539487 ·Status: COMPLETED
-
Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan
NCT01108796 ·Status: COMPLETED
-
A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)
NCT02200653 ·Status: COMPLETED ·Phase: PHASE4
-
A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers
NCT05223101 ·Status: UNKNOWN ·Phase: PHASE1